AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $271,008 | +50.2% | 64,220 | +10.3% | 0.00% | – |
| Q2 2023 | $180,491 | +122.4% | 58,223 | -0.3% | 0.00% | – |
| Q1 2023 | $81,151 | -26.8% | 58,382 | +4.7% | 0.00% | – |
| Q4 2022 | $110,937 | +19.3% | 55,747 | +20.9% | 0.00% | – |
| Q3 2022 | $93,000 | -21.8% | 46,118 | +23.5% | 0.00% | – |
| Q2 2022 | $119,000 | -20.7% | 37,335 | +3.8% | 0.00% | – |
| Q1 2022 | $150,000 | -25.0% | 35,977 | -13.9% | 0.00% | – |
| Q4 2021 | $200,000 | -2.9% | 41,775 | +8.1% | 0.00% | – |
| Q3 2021 | $206,000 | +23.4% | 38,628 | +18.4% | 0.00% | – |
| Q2 2021 | $167,000 | -18.1% | 32,622 | +7.9% | 0.00% | – |
| Q1 2021 | $204,000 | +88.9% | 30,239 | +27.9% | 0.00% | – |
| Q4 2020 | $108,000 | +66.2% | 23,635 | +40.2% | 0.00% | – |
| Q3 2020 | $65,000 | – | 16,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |